Largest Measles Epidemic in North America in a Decade—Quebec, Canada, 2011: Contribution of Susceptibility, Serendipity, and Superspreading Events

Higher Risk of Measles When the First Dose of a 2-Dose Schedule of Measles Vaccine Is Given at 12–14 Months Versus 15 Months of Age

(2012) Gaston De Serres et al.   CLINICAL INFECTIOUS DISEASES

The Americas: Paving the Road Toward Global Measles Eradication

(2011) Carlos Castillo-Solorzano C et al.   JOURNAL OF INFECTIOUS DISEASES

Laboratory Characterization of Measles Virus Infection in Previously Vaccinated and Unvaccinated Individuals

(2011) Carole J. Hickman et al.   JOURNAL OF INFECTIOUS DISEASES

Field Effectiveness of Live Attenuated Measles-Containing Vaccines: A Review of Published Literature

(2011) Amra Uzicanin et al.   JOURNAL OF INFECTIOUS DISEASES

Sero-epidemiology of measles-specific IgG antibodies and predictive factors for low or missing titres in a German population-based cross-sectional study in children and adolescents (KiGGS)

(2011) Christina Poethko-Müller et al.   VACCINE

Long‐Lasting Measles Outbreak Affecting Several Unrelated Networks of Unvaccinated Persons

(2009) Frédéric Dallaire et al.   JOURNAL OF INFECTIOUS DISEASES

Persistence of Measles, Mumps, and Rubella Antibodies in an MMR‐Vaccinated Cohort: A 20‐Year Follow‐up

(2008) Irja Davidkin et al.   JOURNAL OF INFECTIOUS DISEASES

The effect of superspreading on epidemic outbreak size distributions

(2008) T. Garske et al.   JOURNAL OF THEORETICAL BIOLOGY